SPARC expression by cerebral microvascular endothelial cells in vitro and its influence on blood-brain barrier properties

Abstract

BackgroundSPARC (secreted protein acidic and rich in cysteine) is a nonstructural, cell-matrix modulating protein involved in angiogenesis and endothelial barrier function, yet its potential role in cerebrovascular development, inflammation, and repair in the central nervous system (CNS) remains undetermined.MethodsThis study examines SPARC expression in cultured human cerebral microvascular endothelial cells (hCMEC/D3)—an in vitro model of the blood-brain barrier (BBB)—as they transition between proliferative and barrier phenotypes and encounter pro-inflammatory stimuli. SPARC protein levels were quantified by Western blotting and immunocytochemistry and messenger RNA (mRNA) by RT-PCR.ResultsConstitutive SPARC expression by proliferating hCMEC/D3s is reduced as cells mature and establish a confluent monolayer. SPARC expression positively correlated with the proliferation marker Ki-67 suggesting a role for SPARC in cerebrovascular development. The pro-inflammatory molecules tumor necrosis factor-α (TNF-α) and endotoxin lipopolysaccharide (LPS) increased SPARC expression in cerebral endothelia. Interferon gamma (IFN-γ) abrogated SPARC induction observed with TNF-α alone. Barrier function assays show recombinant human (rh)-SPARC increased paracellular permeability and decreased transendothelial electrical resistance (TEER). This was paralleled by reduced zonula occludens-1 (ZO-1) and occludin expression in hCMEC/D3s exposed to rh-SPARC (1–10 μg/ml) compared with cells in media containing a physiological dose of SPARC.ConclusionsTogether, these findings define a role for SPARC in influencing cerebral microvascular properties and function during development and inflammation at the BBB such that it may mediate processes of CNS inflammation and repair.Electronic supplementary materialThe online version of this article (doi:10.1186/s12974-016-0657-9) contains supplementary material, which is available to authorized users.

Brain endothelial cell expression of SPARCL‐1 is specific to chronic multiple sclerosis lesions and is regulated by inflammatory mediators in vitro

“…Founding family member Secreted protein acidic and rich in Cysteine (SPARC), a matricellular protein bearing high structural homology to SPARCL‐1, has recently been reported to increase transendothelial permeability of the blood brain barrier (BBB) in vitro . SPARCL‐1 and SPARC exert antagonistic effects on cell adhesion and excitatory neuron synaptogenesis , but no function for SPARCL‐1 in BBB regulation has been ascribed so far.…”

Long non‑coding RNA SNHG16 inhibits the oxygen‑glucose deprivation and reoxygenation‑induced apoptosis in human brain microvascular endothelial cells by regulating miR‑15a‑5p/bcl‑2

“…Although rapid recanalization of the relevant artery and subsequent promotion of brain revascularization can successfully treat patients, reperfusion can increase the production of reactive oxygen species (ROS), inflammation and endoplasmic reticulum stress, leading to ischemia-reperfusion (I/R) injury, such as human brain microvascular endothelial cell (hBMEC) apoptosis ( 3 ). hBMECs, located between the blood and the brain parenchyma, are essential for normal neurological function and are responsible for transferring essential nutrients and removing potentially harmful toxins ( 4 ). I/R injury-induced hBMEC apoptosis impairs the therapeutic effect of relevant artery recanalization ( 5 – 7 ).…”

Age-related Beta-synuclein Alters the p53/Mdm2 Pathway and Induces the Apoptosis of Brain Microvascular Endothelial Cells In Vitro

“…Under physiological conditions, microvessels throughout most of the CNS possess a monolayer of endothelial cells connected with tight junctions and located between the blood and brain parenchyma, comprising the BBB together with adjacent astrocytes. 16 Numerous studies showed that neurovascular dysfunctions may contribute to the onset and progression of neurodegenerative diseases, such as AD by linking cerebrovascular changes and dysfunction. 17 Recently, the age-dependent deterioration of the BBB during normal aging in the human hippocampus was demonstrated.…”